Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-04-27 Sale | 2020-04-29 7:19 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | GIVEN BRUCE D Chief Operating Officer | 5,401 | $40 | $216,040 | 2,838,205 (Direct) | View |
| 2020-04-20 Sale | 2020-04-22 7:00 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | GIVEN BRUCE D Chief Operating Officer | 23,515 | $40 | $940,600 | 2,213,222 (Direct) | View |
| 2020-01-06 Sale | 2020-01-08 6:35 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | GIVEN BRUCE D Chief Operating Officer | 35,613 | $60.13 | $2,141,285 | 858,993 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2020-04-28 Exercise | 2020-04-29 7:19 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | GIVEN BRUCE D Chief Operating Officer | 500 | $7.75 | 2,838,205 (Direct) | View |
| 2020-04-28 Exercise | 2020-04-29 7:19 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | GIVEN BRUCE D Chief Operating Officer | 1,200 | $4.75 | 2,838,205 (Direct) | View |
| 2020-04-27 Exercise | 2020-04-29 7:19 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | GIVEN BRUCE D Chief Operating Officer | 1,030 | $5.19 | 2,838,205 (Direct) | View |
| 2020-04-27 Exercise | 2020-04-29 7:19 pm | 2012-03-01 2020-02-16 | ARROWHEAD PHARMACEUTICALS INC. | ARWR | GIVEN BRUCE D Chief Operating Officer | 4,397 | $0 | 2,838,205 (Direct) | View |
| 2020-04-28 Exercise | 2020-04-29 7:19 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | GIVEN BRUCE D Chief Operating Officer | 213 | $5.2 | 2,838,205 (Direct) | View |
| 2020-04-28 Exercise | 2020-04-29 7:19 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | GIVEN BRUCE D Chief Operating Officer | 1,454 | $14.54 | 2,838,205 (Direct) | View |
| 2020-04-20 Exercise | 2020-04-22 7:00 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | GIVEN BRUCE D Chief Operating Officer | 3,800 | $4.75 | 2,213,222 (Direct) | View |
| 2020-04-20 Exercise | 2020-04-22 7:00 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | GIVEN BRUCE D Chief Operating Officer | 3,700 | $5.19 | 2,213,222 (Direct) | View |
| 2020-04-20 Exercise | 2020-04-22 7:00 pm | 2013-10-01 2023-09-21 | ARROWHEAD PHARMACEUTICALS INC. | ARWR | GIVEN BRUCE D Chief Operating Officer | 16,256 | $0 | 2,213,222 (Direct) | View |
| 2020-04-20 Exercise | 2020-04-22 7:00 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | GIVEN BRUCE D Chief Operating Officer | 3,456 | $5.2 | 2,213,222 (Direct) | View |
| 2020-04-20 Exercise | 2020-04-22 7:00 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | GIVEN BRUCE D Chief Operating Officer | 5,300 | $14.54 | 2,213,222 (Direct) | View |
| 2020-01-01 Option Award | 2020-01-03 6:04 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | GIVEN BRUCE D Chief Operating Officer | 250,000 | $0 | 894,606 (Direct) | View |